Dr. Francis Collins, Director of the National Institutes of Health, spoke to the ME community earlier this month at the meeting on
Accelerating Research on ME/CFS. For the ten minutes he was present, Dr. Collins
said a lot of nice things. I sincerely want to believe it all.
But I don’t.
I want to believe that the meeting is “a real milestone.” I want to believe that the Trans-NIH ME/CFS Working Group will “bring forward ideas about new projects, new kinds of funding,” and that those ideas will have Dr. Collins’s “strong personal support” and thus become reality.
Except Dr. Collins’s remarks this month were strikingly similar, in many ways, to what he said exactly eight years ago at
NIH’s State of the Knowledge Workshop on ME/CFS Research. In 2011, Dr. Collins pointed out that “we really need to understand a lot more about what subsets might exist.” He said there had been “hopeful presentations” about approaches coming out of new technologies. He expected “new ideas” to come out of that workshop and that “those new ideas might suggest new research.” Subsets, the promise of new technologies, and new ideas. Dr. Collins hit all these same notes in his 2019 remarks.